Cited by 105Drug-Induced Hepatotoxicity and ProtectionPoisoning and overdose treatmentsLiver physiology and pathology

Delayed Treatment With 4-Methylpyrazole Protects Against Acetaminophen Hepatotoxicity in Mice by Inhibition of c-Jun n-Terminal Kinase

Open access
Akakpo, Jephte Y, Ramachandran, Anup, Duan, Luqi, Schaich, Matthew A, Jaeschke, Matthew W, Freudenthal, Bret D, Ding, Wen-Xing, Rumack, Barry H +1 more·2019·Toxicological Sciences

Abstract

Acetaminophen (APAP) overdose is the most common cause of hepatotoxicity and acute liver failure in the United States and many western countries. However, the only clinically approved antidote, N-acetylcysteine, has a limited therapeutic window. 4-Methylpyrazole (4MP) is an antidote for methanol and ethylene glycol poisoning, and we have recently shown that cotreatment of 4MP with APAP effectively prevents toxicity by inhibiting Cyp2E1. To evaluate if 4MP can be used therapeutically, C57BL/6J mice were treated with 300 mg/kg APAP followed by 50 mg/kg 4MP 90 min later (after the metabolism phase). In these experiments, 4MP significantly attenuated liver injury at 3, 6, and 24 h after APAP as shown by 80%-90% reduction in plasma alanine aminotransferase activities and reduced areas of necrosis. 4MP prevented c-Jun c-Jun N-terminal kinase (JNK) activation and its mitochondrial translocation, and reduced mitochondrial oxidant stress and nuclear DNA fragmentation. 4MP also prevented JNK activation in other liver injury models. Molecular docking experiments showed that 4MP can bind to the ATP binding site of JNK. These data suggest that treatment with 4MP after the metabolism phase effectively prevents APAP-induced liver injury in the clinically relevant mouse model in vivo mainly through the inhibition of JNK activation. 4MP, a drug approved for human use, is as effective as N-acetylcysteine or can be even more effective in cases of severe overdoses with prolonged metabolism (600 mg/kg). 4MP acts on alternative therapeutic targets and thus may be a novel approach to treatment of APAP overdose in patients that complements N-acetylcysteine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/toxsci/kfz077

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Akakpo, J. Y., Ramachandran, A., Duan, L., Schaich, M. A., Jaeschke, M. W., Freudenthal, B. D., Ding, W.-X., Rumack, B. H., & Jaeschke, H.
Affiliations
  • Department of Pharmacology Toxicology & Therapeutics
  • University of Kansas Medical Center (US)
  • University of Colorado Anschutz (US)
Corresponding author
Jaeschke, Hartmut
Venue
Toxicological Sciences
Published
2019-03-23
Volume
170
Issue
1
Pages
57-68
ISSN
  • 1096-0929 (ISSN-L)
  • 1096-6080
OpenAlex
W2937650113
Cited by
105
References
64
Citations by year
2026: 5 · 2025: 11 · 2024: 17 · 2023: 17 · 2022: 20 · 2021: 13 · 2020: 18 · 2019: 4
FWCI
13.85
Type
journal article
Language
en
Open access
Locations
  • Toxicological Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • McNeil Consumer Health Care, Inc
  • National Institutes of Health (R01 DK102142)
  • National Institute of General Medical Sciences (P20 GM103549 and P30 GM118247)
  • from the National
  • NIH Predoctoral Fellowship
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
acetaminophen hepatotoxicity, 4-methylpyrazole, c-Jun N-terminal kinase, N-acetylcysteine, acute liver failure, mitochondrial translocation, DNA fragmentation, CYP2E1, molecular docking, drug overdose
MeSH terms
Fomepizole, Acetaminophen, Animals, Male, Mice, Inbred C57BL, Protein Binding, Protein Kinase Inhibitors, JNK Mitogen-Activated Protein Kinases, Chemical and Drug Induced Liver Injury, Time-to-Treatment, Molecular Docking Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review